Awada, H., Mahfouz, R. Z., Kishtagari, A., Kuzmanovic, T., Durrani, J., Kerr, C. M., . . . Saunthararajah, Y. (2019). Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignancies. Br J Haematol.
シカゴスタイル引用形Awada, Hassan, et al. "Extended Experience With a Non‐cytotoxic DNMT1‐targeting Regimen of Decitabine to Treat Myeloid Malignancies." Br J Haematol 2019.
MLA引用形式Awada, Hassan, et al. "Extended Experience With a Non‐cytotoxic DNMT1‐targeting Regimen of Decitabine to Treat Myeloid Malignancies." Br J Haematol 2019.
警告: この引用は必ずしも正確ではありません.